Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
General Healthcare
Filter
Journals
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Mediterranean Diet Found Effective for IBS Relief
November 2025
Mediterranean diet eased irritable bowel syndrome symptoms more effectively than standard dietary guidance in a new UK clinical trial.
Read more
17 Feb 2017
New Data Shows Stelara® (Ustekinumab) Maintained Clinical Response and Remission After Two Years of Treatment in Patients with Moderate to Severe Crohn’s Disease
Barcelona, Spain, February 17, 2017 – Janssen-Cilag International NV (“Janssen”) announced today new two-year data from the ongoing IM-UNITI long-term…
10 Feb 2017
BIAL and Neurocrine Announce Exclusive North American Licensing Agreement for Opicapone
Porto, Portugal and San Diego, California, February 10, 2017 – BIAL and Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that they have…
6 Feb 2017
Mechanical Force Used by Antibiotics to ‘Tear Apart’ Resistant Bacteria
SCIENTISTS have found that antibiotics are still able to kill resistant bacteria by using mechanical force to ‘tear holes in the bacteria and rip them…
5 Feb 2017
Scientists Report New Approach for Developing Safer and More Stable Polio Vaccines
MODIFYING existing ‘virus-like particles’ (VLPs) to create more stabilised structures could represent a new approach to developing more practical…
1 Feb 2017
Urine Samples Used to Detect Bladder Cancer
SCIENTISTS have developed a non-invasive bisulphite sequencing test to detect bladder cancer using urine samples that matches the performance of a…
31 Jan 2017
Scientists Discover Gene That Reduces Mutations in Mycobacteria
A GENE has been discovered that could halt the development of drug-resistant ‘superbugs’ from strains of tuberculosis by reducing…
23 Jan 2017
New Year, New Content!
WITH THE CHRISTMAS HOLIDAYS a mere twinkle of a memory, the festive season has well and truly been and gone, finding ourselves settled into January.
17 Jan 2017
AMRA Announces $9 Million Investment from Pfizer Venture Investments, Novo Seeds and Industrifonden
Sweden, January 17, 2017 – Swedish-based digital health company AMRA has announced today a $9 million funding round co-led by US-based Pfizer Venture…
Loading posts...
« Previous
1
…
34
35
36
37
38
…
47
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View